Cancer Immunology

Search results

• Researchers Find Treatment Options for Patients Whose Blood Cancer Relapses After CAR-T

  Samir Parekh

  4/11/22

  60 items of Media coverage

  Press/Media

• Researchers find treatment options for patients whose blood cancer relapses after CAR-T

  Samir Parekh

  4/11/22

  3 items of Media coverage

  Press/Media

• Therapy Options for Multiple Myeloma Patients Who Relapse upon Immunotherapy

  Samir Parekh

  4/11/22

  1 item of Media coverage

  Press/Media

• A multinational Delphi consensus to end the COVID-19 public health threat

  JOO-WON KIM & Adolfo Garcia-Sastre

  3/11/22

  1 item of Media coverage

  Press/Media

• Accident With 1918 Pandemic Virus Raises Questions About Pathogen Research

  Adolfo Garcia-Sastre

  2/11/22

  1 item of Media coverage

  Press/Media

• Accident With 1918 Pandemic Virus Raises Questions About Pathogen Research

  Adolfo Garcia-Sastre

  2/11/22

  1 item of Media coverage

  Press/Media

• Targeting one immune cell type with another slows cancer growth

  Brian Brown & Miriam Merad

  1/11/22

  1 item of Media coverage

  Press/Media

• Covid-19 spurred a historic vaccine R&D effort. What does it mean for future pandemics?

  Adolfo Garcia-Sastre

  1/11/22

  1 item of Media coverage

  Press/Media

• Accident With 1918 Pandemic Virus Raises Questions About Pathogen Research

  Adolfo Garcia-Sastre

  1/11/22

  1 item of Media coverage

  Press/Media

• Australia Patent: Merck Sharp & Dohme, Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center File Application for 'Newcastle disease viruses and uses thereof'

  Adolfo Garcia-Sastre & Peter Palese

  28/10/22

  1 item of Media coverage

  Press/Media

• What is the key factor in combating severe COVID in older adults?

  Sacha Gnjatic & Miriam Merad

  27/10/22

  1 item of Media coverage

  Press/Media

• Mount Sinai Hospital: Targeting One Type Of Immune Cell With Another Slows Cancer Growth In Preclinical Studies

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia, Miriam Merad & Gurkan Mollaoglu

  26/10/22

  1 item of Media coverage

  Press/Media

• Targeting 1 Type of Immune Cell with Another Slows Cancer Growth in Preclinical…

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia, Miriam Merad & Gurkan Mollaoglu

  26/10/22

  1 item of Media coverage

  Press/Media

• Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies | Mount Sinai

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia, Miriam Merad & Gurkan Mollaoglu

  26/10/22

  1 item of Media coverage

  Press/Media

• Targeting one type of immune cell with another slows cancer growth in preclinical studies

  Miriam Merad & Brian Brown

  26/10/22

  1 item of Media coverage

  Press/Media

• New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models

  Brian Brown & Miriam Merad

  26/10/22

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine: Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia, Miriam Merad & Gurkan Mollaoglu

  25/10/22

  1 item of Media coverage

  Press/Media

• Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies

  Adam Marks, Luisanna Pia, Miriam Merad, Brian Brown, Alessia Baccarini & Gurkan Mollaoglu

  25/10/22

  5 items of Media coverage

  Press/Media

• Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia, Miriam Merad & Gurkan Mollaoglu

  25/10/22

  59 items of Media coverage

  Press/Media

• Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies.

  Brian Brown, Alessia Baccarini, Adam Marks, Luisanna Pia, Miriam Merad & Gurkan Mollaoglu

  25/10/22

  1 item of Media coverage

  Press/Media

• Targeting one type of immune cell with another slows cancer growth in preclinical studies

  Adam Marks, Luisanna Pia, Miriam Merad, Brian Brown, Alessia Baccarini & Gurkan Mollaoglu

  25/10/22

  4 items of Media coverage

  Press/Media

• Samir Parekh, MD, on Improving Survival in Multiple Myeloma With Sequential T-Cell Redirection Therapies

  Samir Parekh

  17/10/22

  1 item of Media coverage

  Press/Media

• Labroots Hosts 8th Event in its Coronavirus Virtual Event Series on October 19, 2022

  Adolfo Garcia-Sastre

  13/10/22

  12 items of Media coverage

  Press/Media

• Labroots Hosts 8th Event in its Coronavirus Virtual Event Series on October 19, 2022.

  Adolfo Garcia-Sastre

  13/10/22

  1 item of Media coverage

  Press/Media

• Can Technology Make Humans ‘Super’?

  Brian Brown & Alessia Baccarini

  13/10/22

  1 item of Media coverage

  Press/Media